| Bioactivity | Ametantrone acetate (NSC 196473 acetate) is an antineoplastic drug with topoisomerase II inhibitory activity. Ametantrone acetate causes covalent cross-linking of DNA. The pharmacokinetic profile of Ametantrone acetate has been confirmed in clinical trials, and its elimination pathway in the body indicates the existence of a major metabolic pathway[1]. |
| CAS | 70711-40-9 |
| Formula | C26H36N4O8 |
| Molar Mass | 532.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lee CH, et al. Anthracenedione-methionine conjugates are novel topoisomerase II-targeting anticancer agents with favorable drug resistance profiles. Biochem Pharmacol. 2012;83(9):1208-1216. [2]. Pharmacokinetics of ametantrone acetate (NSC-287513) |
Ametantrone acetate
CAS: 70711-40-9 F: C26H36N4O8 W: 532.59
Ametantrone acetate (NSC 196473 acetate) is an antineoplastic drug with topoisomerase II inhibitory activity. Ametantron
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.